Single Session Intervention to Prevent Common Mental Disorders and Among College Students

Depression, Anxiety Clinical Trial

Official title:

Single Session Intervention to Prevent Common Mental Disorders and Among College Students

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04267068
• Other study ID #: 1219218
• Status: Completed
• Phase: N/A
• Start date: August 5, 2019
• Est. completion date: July 13, 2020

Study information

• Verified date: November 2020
• Source: University of Nevada, Reno
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on depression and anxiety symptom severity. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention

Description:

Depression and anxiety disorders (or common mental disorders; CMDs) are increasingly common among college students, with rates comparable to the general population. As such, brief, scalable and transdiagnostic prevention efforts targeting CMDs are needed. In order to address this need, this study aims to evaluate the impact of a single session intervention (SSI) utilizing growth mindset (GM) on CMD symptom severity and investigate the mediating role of changes in modifiable risk factors in the relationship between intervention and CMD symptom reduction. The intervention will adapt existing GM interventions for college students to engage mechanisms in the prevention and management of common mental disorders including engagement in modifiable risk factors. College students will be randomly assigned to complete either a GM intervention or a psychoeducation control.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 375
• Est. completion date: July 13, 2020
• Est. primary completion date: July 13, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 17 Years to 26 Years

Eligibility

Inclusion Criteria:

• Age 17-26

• College student at the University of Nevada, Reno

Exclusion Criteria:

• Under the age of 17, over the age of 26

• Participated in pilot study

• Not a college student at the University of Nevada, Reno

Related Conditions & MeSH terms

• Depression, Anxiety
• Mental Disorders
• Psychotic Disorders

Intervention

Behavioral:
• Growth Mindset and Modifiable Risk Factor Information
15 minute interactive article describing neuroplasticity followed by 15 minute interactive article describing modifiable risk factors for depression and anxiety
• Control
30 minute interactive article describing symptoms of depression and anxiety, common concerns of college student

Locations

Country	Name	City	State
United States	University of Nevada, Reno	Reno	Nevada

Sponsors (1)

Lead Sponsor	Collaborator
University of Nevada, Reno

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)	9-item questionnaire associated containing one item for each symptom of MDD as specified by the DSM. Items consist of a 4-point Likert scale (0="Not at all" to 3="Nearly every day"). Minimum score is 0, maximum score is 27. Higher scores indicate greater depression severity.	6 months
Primary	Generalized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)	7-item scale, common, brief measure of anxiety symptom severity. Items consist of a 4-point Likert scale (0="Not at all" to 3="Nearly every day"). Minimum score is 0, maximum score is 21. Higher scores indicate greater anxiety symptom severity.	6 months